Induction of apoptosis of tumor cells by binase

Molekulyarnaya Biologiya

Volumn 39, Issue 3, 2005, Pages 457-463

  Zelenikhin, P V ^a   Kolpakov, A I ^a   Cherepnev, G V ^b   Ilinskaya, O N ^a,c  

^a KAZAN FEDERAL UNIVERSITY   (Russian Federation)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; BINASE; DNA FRAGMENT; HISTIDINE; LYSINE; RIBONUCLEASE; UNCLASSIFIED DRUG; RIBONUCLEASE T2;

APOPTOSIS; ARTICLE; BACILLUS; BACILLUS INTERMEDIUS; BLOOD CELL; CANCER CELL; CARCINOMA CELL; CATALYSIS; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ERYTHROLEUKEMIA CELL; HUMAN; HUMAN CELL; LUNG CARCINOMA; MOLECULAR WEIGHT; MONONUCLEAR CELL; MYELOID LEUKEMIA; TUMOR CELL; WILD TYPE; AMINO ACID SUBSTITUTION; CARCINOMA; CELL STRAIN K 562; DRUG EFFECT; GENETICS; LUNG TUMOR; PATHOPHYSIOLOGY; POINT MUTATION;

BACILLUS INTERMEDIUS; BACTERIA (MICROORGANISMS);

AMINO ACID SUBSTITUTION; CARCINOMA; DNA FRAGMENTATION; ENDORIBONUCLEASES; HUMANS; K562 CELLS; LUNG NEOPLASMS; POINT MUTATION;

EID: 22944446130     PISSN: 00268984     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Saxena S.K., Shogen K., Ardelt W. 2003. Onconase and its therapeutic potential. Lab. Med. 34, 380-387.
2. Antignani A., Naddo M., Cubellis M.V., Russo A., D'Alessio G. 2001. Antitumor action of seminal ribonuclease, its dimeric structure, and its resistance to the ribonuclease inhibitor. Biochemistry. 40, 3492-3496.
3. Cinatl Jr.J., Cinatl J., Kotchetkov R., Matousek J., Woodcock B.G., Koehi U., Vogel J.U., Kornhuber B., Schwabe D. 2000. Bovine seminal ribonuclease exerts selective cytotoxicity toward neuroblastoma cells both sensitive and resistant to chemotherapeutic drugs. Anticancer Res. 20, 853-859.
4. Olmo N., Turnay J., Gonzalez de Butitrago G., Lopez de Silanes I., Gavilanes J.G., Lizarbe M.A. 2001. Cytotoxic mechanism of the ribotoxin alpha-sarcin. Induction cell death via apoptosis. Eur. J. Biochem. 268, 2113-2123.
5. Sevcik J., Urbanikova L., Leland P.A., Raines R.T. 2002. X-Ray structure of two crystalline forms of a Streptomycete ribonuclease with cytotoxic activity. J. Biol. Chem. 277, 47325-47330.
6. Ran S., Downes A., Thorpe P.E. 2002. Increased exposure of anionic phospholipids on the surface of tumor blood vessels. Cancer Res. 62, 6132-6140.
7. Makarov A.A., IIinskaya O.N. 2003. Cytotoxic ribonucleases: molecular weapons and their targets. FEBS Lett. 540, 15-20.
8. Grabarek J., Ardelt B., Du L., Darzynkiewicz Z. 2002. Activation of caspases and serine proteases during apoptosis induced by onconase (Rapirnase). Exp. Cell Res. 278, 61-71.
9. Spalletti-Cernia D., Sorrentino R., Di Gaetano S., Piccoli R., Santoro V., D'Alessio G., Laccetti P., Vacchio G. 2004. Higly selective toxic and proapoptotic effects of two dimeric ribonucleases on thyroid cancer cells compared to the effects of doxorubicin. Brit. J. Cancer. Res. 90, 270-277.
10. IIinskaya O., Decker K., Koschinski A., Dreyer F., Repp H. 2001. Bacillus intermedius ribonuclease as inhibitor of cell proliferation and membrane current. Toxicology. 156, 101-107.
11. Scharovsky O.G., Rozados V.R., Gervasoni S.I., Matar P. 2000. Inhibition of ras oncogene: a novel approach to antineoplastic therapy. J. Biochem. Sci. 7, 292-298.
12. Corcoran G.B., Fix L., Jones D.P., Moslen M.T., Nicotera P., Oberhammer F.A., Buttyan R. 1994. Apoptosis: molecular control point in toxicity. Toxicol. Appl. Pharmacol. 113, 167-183.
13. Blaszczyk J., Gan J., Tropea J.E., Court D.L., Waugh D.S., Ji X. 2004. Noncatalytic assembly of ribonuclease III with double-stranded RNA. Structure (Camb). 12, 457-466.
14. Yakovlev G.I., Moiseyev G.P., Struminskaya N.K., Borzykh O.A., Kipenskaya L.V., Znamenskaya L.V., Leschinskaya I.B. 1994. Mutational analysis of the active site of RNase of Bacillus intermedius (BINASE). FEBS Lett. 354, 305-306.
15. Ilinskaya O.N., Ivanchenko O.B., Karamova N.S., Kipenskaya L.V. 1996. SOS-inducing ability of native and mutant microbial ribonucleases. Mutat. Res. 354, 203-209.
16. Juan G., Gruenwald S., Darzynkiewicz Z. 1998. Phosphorylation of retinoblastoma susceptibility gene protein assayed in individual lymphocytes during their mitogenic stimulation. Exp. Cell Res. 239, 104-110.
17. Laakko T., King L., Fraker P. 2002. Versatility of merocyanine 540 for the flow cytometric detection of apoptosis in human and murine cells. J. Immunol. Meth. 261, 129-139.
18. Gaforio J., Serrano M., Algarra I., Ortega E., Alvarez de Cienfuegos G. 2002. Phagocytosis of apoptotic cells assessed by flow cytometry using 7-Aminoactinomycin D. Cytometry. 49, 8-11.
19. Vock E., Lutz W., Ilinskaya O., Vamvakas S. 1999. Discrimination between genotoxicity and cytotoxicity for the induction of DNA double-strand breaks in cells treated with aldehydes and diepoxides. Mutat. Res. 441, 85-93.
20. Vock E., Vamvakas S., Gahlmann R., Lutz W. 1998. Investigation of the induction of DNA double-strand breaks by methylenediphenyl-4-4′- diisocyanate in cultured human lung epithelial cells. Toxicol. Sci. 46, 83-89.
21. Smolewski P., Grabarek J., Lee B., Johnson G., Darzynkiewicz Z. 2002. Kinetics of HL-60 cell entry to apoptosis during treatment with TNF-alpha or camptothecin assayed by the stathmo-apoptosis method. Cytometry. 47, 143-149.
22. Thomas S., Preda-Paris A., Casares S., Brumeanu T.D. 2004. RNA degradation precedes DNA clevage in autoreactivated CD4 T cells supressed by calicheamicin gamma1. Int. Immunopharmacol. 4, 521-526.
23. Okumura K., Itoh A., Isogai E., Hirose K., Hosokawa Y., Abiko Y., Shibata T., Hitara M., Isogai H. 2004. C-terminal domain of human CAP18 antimicrobial peptide induces apaptosis in oral squamous cell carcinoma SASH1 cells. Cancer Lett. 212, 185-194.
24. Ioannou Y.A., Chen F.W. 1996. Quantitation of DNA fragmentation in apoptosis. Nucleic Acids Res. 24, 992-993.
25. Frisch S.M. 1999. Methods for studying anoikis. Methods Mol. Biol., 129, 251-256.
26. Hursey M., Newton D.L., Hansen H.J., Ruby D., Goldenberg D.M., Rybak S.M. 2002. Specifically targeting the CD22 receptor of human B-cell lymphomas with RNA damaging agents: a new generation of therapeutics. Lenk. Lymphoma. 43, 953-959.
27. Yuki S., Kondo Y., Kato F., Matsuo N. 2004. Noncytotoxic ribonyclease, RNase T1, induces tumor cell death via hemasglutinating virus of Japan envelope vector. Eur. J. Biochem. 271, 3567-3572.
28. Kubota K., Nakahara K., Ohtsuka T., Yoshida S., Kawaguchi J., Fujita Y., Okzaki Y., Hara A., Yoshimura C., Furukawa H., Haruyama H., Ichikawa K., Yamashita M., Matsuoka T., Iijima Y. 2004. Identification of 2′phosphodiesterase, which plays a role in the 2-5A system regulated by interferon. J. Biol. Chem. 279, 37832-37841.
29. Goswami B.B., Kulka M., Ngo D., Cebula T.F. 2004. Apoptosis induced by a cytopathic hepatitus A virus is dependent on caspase activation following ribosomal RNA degradation but occures in the absence of 2′-5′ oligoadenilate synthetase. Antiviral Res. 63, 153-166.
30. Bellacosa A., Moss E.G. 2003. RNA repair: damage control. Current Biol. 13, R482-R484.